Therefore, despite some potential beneficial effects of HIF-1α, overall, both HIF-1α and HIF-2α are currently thought to be involved in different stages of tumor development, their activity being modulated by numerous mutations, which are associated with tumor progression (Figure 3). The gene discussed is EPAS1; the disease is neoplasm.